News roundup Monday, May 19
News roundup Monday, May 19
| Published July 10, 2023

News roundup Monday, July 10

NeoDynamics

The latest from BioStock

Read BioStock's newsletter for v.27 here.


Watch the latest episode of The Stock Exchange Round!

Stock Market Roundup week 27


Morning news

presented results from their PULSE study at the annual congress of German Society of Senology which was held last week. Read more.

Cereno Scientific attending Pulmonary Vascular Research Institutes 8th Annual Drug Discovery & Development Symposium. Read more.

Mendus has published a communiqué from the extraordinary general meeting held on July 10, 2023. Read more.

Neola Medicals vd Hanna Sjöström tells you more about the latest news in this summer's investor letter. Read more.

The two incentive programs for WntResearch which was decided by the extraordinary general meeting on June 30, 2023 has now been implemented. Read more.

Brain+ announces that the FDA approval of the Alzheimer's drug Lecanemab is good news for Brain+. Read more.

Björn Larsson leaves his position as CEO of RLS Global with immediate effect. Roland Frösing, board member since 2021, is acting CEO as of today, July 10. Read more.

SensoDetect is expanding the number of negotiations with hospitals in the Middle East. Read more.


News since Friday lunch

The publication of BrainCools thrombectomy study was accepted for publication in Stroke & Vascular Neurology. Read more.

Spermosis announced that it is raising a loan of SEK 8,7 million to ensure continued market preparation activities. Read more.

Arctic Bioscience announced an established credit facility of NOK 30 million. Read more.

FluoGuide announced an extraordinary general meeting on July 25. Read more.

Interview with SUFFER chairman of the board Pontus Ottosson published on the company's website. Read more.

BioPorto invited to a webcast for the presentation of the company's Q2 report. Read more.

Vicore Pharma published a prospectus for admission to trading of shares on Nasdaq Stockholm. Read more.

QuiaPEG Pharmaceuticals called for an extraordinary general meeting. Read more.

Idogen was declared bankrupt and Nasdaq delisted the stock from Nasdaq First North. Read more.

Redsense Medicals alarm system alerted by KFF Health News. Read more.

Henrik Bergentoft leaves the role as CFO in RaySearch Laboratories. Read more.

Orthoma has had two abstracts accepted for presentation at the ISTA congress taking place in New York, September 27-30, 2023. Read more.

Invitation to presentation of Q-lineas interim report for quarter 2, 2023 on July 13, 2023. Read more.

Nykode Therapeutics announced an employee stock option program. Read more.

Coala Life presented key figures for the United States for the month of June. Read more.

Attana published a summer update to its shareholders. Read more.

Mentice will present the company's Q2 report via a webcast on July 20. Read more.

Elekta published the annual report for 2022/2023. Read more.

Bactiguard Holding announced that the company's EBITDA for Q2 and full year 2023 will be negatively impacted by SEK 42 million due to one-time provisions. Read more.


This morning's price development

Winner: Pila Pharma +11,42%, Amniotics +9,41%, Promimic +8,46%, Klaria Pharma +7,72%

Förlorare: Lipidor -15,36%, Redwood Pharma -12,62%, Spago Nanomedical -11,48%, Diagonal Bio -10,20%

IndexOMSX30 -0,34% Healthcare -0,58%